CD70 CAR T-cells
/ Shanghai Yake Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 04, 2021
CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
(clinicaltrials.gov)
- P1; N=108; Recruiting; Sponsor: Zhejiang University; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Acute Myelogenous Leukemia • Hematological Disorders • Hematological Malignancies • Leukemia • Lymphoma • Multiple Myeloma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1